Back to
XTX Topco Ltd
ARQT
Showing 8 of 14 quarters
Position history for
XTX Topco Ltd's holdings in Arcutis Biotherapeutics, Inc.
Yes. XTX Topco holds 45,545 shares of ARQT (Arcutis Biotherapeutics), worth $1.2M, as of its Q2 2026 13F filing. It increased the position by 2,861 shares (+6.7%) from Q1 2026. XTX Topco has held ARQT since Q1 2025, across 6 quarterly 13F filings.
Current Value
$1.2M
Current Shares
45,545
Total Value Change
+$750,320
Total Shares Change
-2,183
Quarter-by-Quarter History